Optimizing the cost-effectiveness of treatment for chronic kidney disease-mineral and bone disorder

Chronic kidney disease-mineral and bone disorder (CKD-MBD) is an important risk factor in patients with CKD, and some medications for treating CKD-MBD have been recently marketed. Because assessment of health-care cost-effectiveness is growing in importance with increases in health expenditures, sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Shunsuke, Komaba, Hirotaka, Fukagawa, Masafumi, Nishi, Shinichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089630/
https://www.ncbi.nlm.nih.gov/pubmed/25019030
http://dx.doi.org/10.1038/kisup.2013.95

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089630/
https://www.ncbi.nlm.nih.gov/pubmed/25019030
http://dx.doi.org/10.1038/kisup.2013.95

Ejemplares similares